UTD GENE HI-TEC
UTD GENE HI-TEC operates in Diversified Metals & Mining.
UTD GENE HI-TEC (FRHN) - Total Liabilities
Latest total liabilities as of March 2024: €1.06 Billion EUR
Based on the latest financial reports, UTD GENE HI-TEC (FRHN) has total liabilities worth €1.06 Billion EUR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UTD GENE HI-TEC - Total Liabilities Trend (2017–2024)
This chart illustrates how UTD GENE HI-TEC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UTD GENE HI-TEC Competitors by Total Liabilities
The table below lists competitors of UTD GENE HI-TEC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Puma VCT 13 PLC
LSE:PU13
|
UK | GBX844.00K |
|
AHLERS - Dusseldorf Stock Exchang
DU:AAH
|
Germany | €105.97 Million |
|
Aeon Ventures Inc
PINK:IDEA
|
USA | $147.25K |
|
Big Screen Entertainment Group Inc
PINK:BSEG
|
USA | $291.61K |
|
Imperial Resources Inc
PSE:IMP
|
Philippines | ₱70.39 Million |
|
Devoran SA
WAR:DEV
|
Poland | zł395.00K |
|
United American Healthcare Corp
PINK:UAHC
|
USA | $96.00K |
Liability Composition Analysis (2017–2024)
This chart breaks down UTD GENE HI-TEC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UTD GENE HI-TEC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UTD GENE HI-TEC (2017–2024)
The table below shows the annual total liabilities of UTD GENE HI-TEC from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-03-31 | €1.06 Billion | -14.47% |
| 2023-03-31 | €1.24 Billion | +24.38% |
| 2022-03-31 | €999.73 Million | -4.29% |
| 2021-03-31 | €1.04 Billion | +22.72% |
| 2020-03-31 | €851.11 Million | +8.57% |
| 2019-03-31 | €783.94 Million | +21.10% |
| 2018-03-31 | €647.34 Million | +17.14% |
| 2017-03-31 | €552.64 Million | -- |